EICHORCondition: Ovarian Germ Cell Cancer · Ovarian Neoplasms · Ovarian Cancer · Sponsor: Beihua Kong
Investigators will conduct the trial to determine whether paclitaxel and cisplatin (PT) has the same curative effects and less adverse effects than bleomycin, etoposide and cisplatin(BEP) among newly diagnosed malignant ovarian germ cell tumor patients after surgery.
This description comes directly from the study's public registry record.
Beihua Kong, MD. PhD. · +8618560081888 · kongbeihua@sdu.edu.cn
Always discuss trial participation with your own doctor first.
| Qilu Hospital of Shandong University | Jinan, Shandong, China | Recruiting |
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02429687